Qiang Shen

6PUBLICATIONS
14CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Biologically active moleculesChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 05, 2021
GRB2 enforces homology-directed repair initiation by MRE11.

Zu Ye, Shengfeng Xu, Yin Shi

|Feb 06, 2020
HJC0152 suppresses human non-small-cell lung cancer by inhibiting STAT3 and modulating metabolism.

Lu Lu, Hang Li, Xin Wu

|Jun 02, 2018
Activation of STAT3 and Bcl-2 and reduction of reactive oxygen species (ROS) promote radioresistance in breast cancer and overcome of radioresistance with niclosamide.

Lu Lu, Jiali Dong, Lili Wang

|Feb 23, 2018
Therapeutic Potential of Oridonin and Its Analogs: From Anticancer and Antiinflammation to Neuroprotection.

Jimin Xu, Eric A Wold, Ye Ding

|Dec 01, 2017
MiR-519d-3p suppresses breast cancer cell growth and motility via targeting LIM domain kinase 1.

Dengfeng Li, Hongming Song, Tianqi Wu

|Oct 12, 2017
Mechanistic Evaluation and Translational Signature of Gemcitabine-induced Chemoresistance by Quantitative Phosphoproteomics Analysis with iTRAQ Labeling Mass Spectrometry.

Qingke Duan, Hengqiang Zhao, Zhengle Zhang

Pageof 1

Frequent Collaborators

1 joint publications

Eric A Wold

1 joint publications

Jia Zhou

1 joint publications

Zu Ye

1 joint publications

Shengfeng Xu